Filing Details

Accession Number:
0001209191-17-005350
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-24 17:52:40
Reporting Period:
2017-01-20
Filing Date:
2017-01-24
Accepted Time:
2017-01-24 17:52:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401667 Puma Biotechnology Inc. PBYI Pharmaceutical Preparations (2834) 770683487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678610 Robert Charnas C/O Puma Biotechnology, Inc.
10880 Wilshire Boulevard, Suite 2150
Los Angeles CA 90024
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-01-20 2,293 $33.24 29,407 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.90 to $33.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.